AAAAAA
Results:
1-21
|
Results: 21
Authors:
Boeckh, M
Bowden, RA
Storer, B
Chao, NJ
Spielberger, R
Tierney, DK
Gallez-Hawkins, G
Cunningham, T
Blume, KG
Levitt, D
Zaia, JA
Citation: M. Boeckh et al., Randomized, placebo-controlled, double-blind study of a cytomegalovirus-specific monoclonal antibody (MSL-109) for prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation, BIOL BLOOD, 7(6), 2001, pp. 343-351
Authors:
Crippa, F
Corey, L
Chuang, EL
Sale, G
Boeckh, M
Citation: F. Crippa et al., Virological, clinical, and ophthalmologic features of cytomegalovirus retinitis after hematopoietic stem cell transplantation, CLIN INF D, 32(2), 2001, pp. 214-219
Authors:
Marr, K
Boeckh, M
Citation: K. Marr et M. Boeckh, Practice guidelines for fungal infections: A risk-guided approach, CLIN INF D, 32(2), 2001, pp. 321-321
Authors:
Boeckh, M
Berrey, MM
Bowden, RA
Crawford, SW
Balsley, J
Corey, L
Citation: M. Boeckh et al., Phase 1 evaluation of the respiratory syncytial virus-specific monoclonal antibody palivizumab in recipients of hematopoietic stem cell transplants, J INFEC DIS, 184(3), 2001, pp. 350-354
Authors:
Limaye, AP
Huang, ML
Leisenring, W
Stensland, L
Corey, L
Boeckh, M
Citation: Ap. Limaye et al., Cytomegalovirus (CMV) DNA load in plasma for the diagnosis of CMV disease before engraftment in hematopoietic stem-cell transplant recipients, J INFEC DIS, 183(3), 2001, pp. 377-382
Authors:
Nichols, WG
Boeckh, M
Citation: Wg. Nichols et M. Boeckh, Response: Rising cytomegalovirus antigenemia on preemptive therapy: practical aspects, BLOOD, 98(5), 2001, pp. 1629-1629
Authors:
Nichols, WG
Corey, L
Gooley, T
Davis, C
Boeckh, M
Citation: Wg. Nichols et al., Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome, BLOOD, 98(3), 2001, pp. 573-578
Authors:
Nichols, WG
Corey, L
Gooley, T
Drew, WL
Miner, R
Huang, ML
Davis, C
Boeckh, M
Citation: Wg. Nichols et al., Rising pp65 antigenemia during preemptive anticytomegalovinus therapy after allogeneic hematopoietic stem cell transplantation: risk factors, correlation with DNA load, and outcomes, BLOOD, 97(4), 2001, pp. 867-874
Authors:
Storek, J
Dawson, MA
Storer, B
Stevens-Ayers, T
Maloney, DG
Marr, KA
Witherspoon, RP
Bensinger, W
Flowers, MED
Martin, P
Storb, R
Appelbaum, FR
Boeckh, M
Citation: J. Storek et al., Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation, BLOOD, 97(11), 2001, pp. 3380-3389
Authors:
Nichols, WG
Boeckh, M
Citation: Wg. Nichols et M. Boeckh, Recent advances in the therapy and prevention of CMV infections, J CLIN VIRO, 16(1), 2000, pp. 25-40
Authors:
Wagner, JL
Seidel, K
Boeckh, M
Storb, R
Citation: Jl. Wagner et al., De novo chronic graft-veusus-host disease in marrow graft recipients givenmethotrexate and cyclosporine: Risk factors and survival, BIOL BLOOD, 6(6), 2000, pp. 633-639
Authors:
Gaviria, JM
Garcia, PJ
Garrido, SM
Corey, L
Boeckh, M
Citation: Jm. Gaviria et al., Nontuberculous mycobacterial infections in hematopoietic stem cell transplant recipients: Characteristics of respiratory and catheter-related infections, BIOL BLOOD, 6(4), 2000, pp. 361-369
Authors:
Marr, KA
Boeckh, M
Citation: Ka. Marr et M. Boeckh, Prophylaxis against fungal infections and cytomegalovirus disease after bone marrow transplantation - The Wilkin/Feinberg article reviewed, ONCOLOGY-NY, 14(12), 2000, pp. 1712
Authors:
Limaye, AP
Corey, L
Koelle, DM
Davis, CL
Boeckh, M
Citation: Ap. Limaye et al., Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants, LANCET, 356(9230), 2000, pp. 645-649
Authors:
Marr, KA
Seidel, K
Slavin, MA
Bowden, RA
Schoch, HG
Flowers, MED
Corey, L
Boeckh, M
Citation: Ka. Marr et al., Prolonged fluconazole prophylaxis is associated with persistent protectionagainst candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial, BLOOD, 96(6), 2000, pp. 2055-2061
Authors:
Price, TH
Bowden, RA
Boeckh, M
Bux, J
Nelson, K
Liles, WC
Dale, DC
Citation: Th. Price et al., Phase I/II trial of neutrophil transfusions from donors stimulated with G-CSF and dexamethasone for treatment of patients with infections in hematopoietic stem cell transplantation, BLOOD, 95(11), 2000, pp. 3302-3309
Authors:
Souza, JP
Boeckh, M
Gooley, TA
Flowers, MED
Crawford, SW
Citation: Jp. Souza et al., High rates of Pneumocystis carinii pneumonia in allogeneic blood and marrow transplant recipients receiving dapsone prophylaxis, CLIN INF D, 29(6), 1999, pp. 1467-1471
Authors:
Boeckh, M
Gooley, T
Leisenring, W
Myerson, D
Corey, L
Citation: M. Boeckh et al., Does high-dose prophylactic acyclovir add benefit in allogeneic marrow transplant recipients receiving prophylactic or preemptive ganciclovir? Reply, J INFEC DIS, 180(2), 1999, pp. 572-574
Authors:
Xun, CQ
McSweeney, PA
Boeckh, M
Storb, RF
Broudy, VC
Thompson, JA
Citation: Cq. Xun et al., Successful nonmyeloablative allogeneic hematopoietic stem cell transplant in an acute leukemia patient with chemotherapy-induced marrow aplasia and progressive pulmonary aspergillosis, BLOOD, 94(9), 1999, pp. 3273-3276
Authors:
Holmberg, LA
Boeckh, M
Hooper, H
Leisenring, W
Rowley, S
Heimfeld, S
Press, O
Maloney, DG
McSweeney, P
Corey, L
Maziarz, RT
Appelbaum, FR
Bensinger, W
Citation: La. Holmberg et al., Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation, BLOOD, 94(12), 1999, pp. 4029-4035
Authors:
Boeckh, M
Bowden, RA
Gooley, T
Myerson, D
Corey, L
Citation: M. Boeckh et al., Successful modification of a pp65 antigenemia-based early treatment strategy for prevention of cytomegalovirus disease in allogeneic marrow transplant recipients, BLOOD, 93(5), 1999, pp. 1781-1782
Risultati:
1-21
|